Oragenics, Inc.OGENNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+64.8%
5Y CAGR+24.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+64.8%/yr
vs +47.7%/yr prior
5Y CAGR
+24.1%/yr
Recent acceleration
Acceleration
+17.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 73.42% |
| Q2 2025 | -24.94% |
| Q1 2025 | -0.33% |
| Q4 2024 | 8.47% |
| Q3 2024 | 11.36% |
| Q2 2024 | -22.12% |
| Q1 2024 | 2.41% |
| Q4 2023 | 31.65% |
| Q3 2023 | 19.43% |
| Q2 2023 | -10.68% |
| Q1 2023 | 41.39% |
| Q4 2022 | -27.31% |
| Q3 2022 | 16.39% |
| Q2 2022 | -21.57% |
| Q1 2022 | 23.55% |
| Q4 2021 | 27.22% |
| Q3 2021 | -38.18% |
| Q2 2021 | -30.67% |
| Q1 2021 | 65.20% |
| Q4 2020 | 18.46% |
| Q3 2020 | 24.95% |
| Q2 2020 | -46.79% |
| Q1 2020 | 69.12% |
| Q4 2019 | 5.32% |
| Q3 2019 | -16.85% |
| Q2 2019 | 4.62% |
| Q1 2019 | -4.90% |
| Q4 2018 | -12.91% |
| Q3 2018 | 16.98% |
| Q2 2018 | 27.22% |
| Q1 2018 | 33.23% |
| Q4 2017 | -35.45% |
| Q3 2017 | 16.89% |
| Q2 2017 | -8.54% |
| Q1 2017 | -7.17% |
| Q4 2016 | -15.41% |
| Q3 2016 | 19.68% |
| Q2 2016 | -7.41% |
| Q1 2016 | -0.57% |
| Q4 2015 | 17.13% |